Avatar

CAR T and NK Cell Therapy in Myeloma

By Parameswaran Hari 5 Videos
August 2018
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
UChicago Medicine Comprehensive Cancer Center

UChicago Annual Updates from ASH 2019

Fri, Feb 28, 2020
Indy Hematology Review

17th Indy Hematology Review

Sat, Mar 21, 2020
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

Fri, Feb 7, 2020
23:48
UChicago CAR T-Cell Symposium 2019

2019 Update on CAR-T in Multiple Myeloma - Can We Improve Upon These Res...

Feat. J. Jasielec
22:47
UChicago CAR T-Cell Symposium 2019

Patient Selection for CAR T-Cell Therapy: Therapeutic Benefits, Discussi...

Feat. M. Leukam
27:06
UChicago CAR T-Cell Symposium 2019

Why Does CAR T-Cell Therapy Fail? An Update on Mechanisms of Resistance/...

Feat. J. Kline
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

07:23
Indy Hematology Review

Novel Immune Therapies in Myeloma: BCMA Immunotoxin, Bites, and CAR T cells

Feat. K. Anderson
17:44
UChicago CAR T-Cell Symposium 2019

Current Grading and Management Strategies of CAR-T Toxicities: Cytokine ...

Feat. S. Kosuri
06:41
UChicago CAR T-Cell Symposium 2019

Mechanisms of Acquired CAR-T Cell Resistance: Is There a 'Best' in Produ...

Feat. J. Labelle
12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

15:47
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
13:30
Helen Heslop

CAR T-cell Therapy for Hematologic Malignancies Other Than CD19

14:43
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?

Feat. R. Orlowski
09:46
2018 Pan Pacific Lymphoma Conference

CAR T-cell Toxicities and Team Management

Feat. S. Blumel
10:38
Krina Patel

How Do We Make Responses Durable in Multiple Myeloma?

22:21
UChicago CAR T-Cell Symposium 2019

Immune Regulation and Chimeric Antigen Receptor (CAR) T-Cell Therapy: Me...

Feat. J. Labelle
16:59
Nina Shah

The Future of CAR T Therapies in Myeloma in 2018

03:34
Krina Patel

The Future in Multiple Myeloma: BiTE, CAR T, PI, & IMID

18:44
City of Hope

The Promise of Immunotherapy and Newer Agents in Multiple Myeloma

Feat. A. Krishnan
29:33
KU Hematology & Medical Oncology Review 2019

What Is CAR T-Cell Therapy? Overcoming Limitations of Current CARs, Revi...

Feat. M. Hoffmann
12:41
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Non-Antibody Based Immune Therapy for Multiple Myeloma: T-Cell Therapies...

Feat. N. Shah